These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2568340)

  • 21. Treatment of ulcerative colitis with olsalazine and sulphasalazine: efficacy and side-effects.
    Ewe K; Eckardt V; Kanzler G
    Scand J Gastroenterol Suppl; 1988; 148():70-5. PubMed ID: 2906479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis.
    Allgayer H; Kruis W; Eisenburg J; Paumgartner G
    Eur J Clin Pharmacol; 1984; 26(2):275-7. PubMed ID: 6144549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ulcerative colitis in West Indian immigrants.
    Benfield GF; Asquith P
    Q J Med; 1986 May; 59(229):489-95. PubMed ID: 2876456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Individualized sulfasalazine treatment of ulcerative colitis and monitoring of patient compliance by determining sulfapyridine serum concentration].
    Klugmann HJ; Giehler B; Lohmann D; Schiedewitz W
    Gastroenterol J; 1990; 49(4):160-4. PubMed ID: 1970478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for the treatment of ulcerative colitis in remission.
    Ardizzone S; Molteni P; Bollani S; Bianchi Porro G
    Eur J Gastroenterol Hepatol; 1997 Sep; 9(9):836-41. PubMed ID: 9355779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is continuous sulfasalazine necessary in the management of patients with ulcerative colitis? Results of a preliminary study.
    Dickinson RJ; King A; Wight DG; Hunter JO; Neale G
    Dis Colon Rectum; 1985 Dec; 28(12):929-30. PubMed ID: 2866071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrograde colonic spread of sulphasalazine enemas.
    Kruis W; Büll U; Eisenburg J; Paumgartner G
    Scand J Gastroenterol; 1982 Oct; 17(7):933-8. PubMed ID: 6130596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Controlled trial comparing olsalazine and sulphasalazine for maintenance treatment of ulcerative colitis.
    Jewell DP; Ireland A
    Scand J Gastroenterol Suppl; 1988; 148():45-7. PubMed ID: 2906477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfasalazine-induced exacerbation of ulcerative colitis.
    Schwartz AG; Targan SR; Saxon A; Weinstein WM
    N Engl J Med; 1982 Feb; 306(7):409-12. PubMed ID: 6120459
    [No Abstract]   [Full Text] [Related]  

  • 30. Sulphasalazine treatment and the colorectal mucosa-associated flora in ulcerative colitis.
    Hartley MG; Hudson MJ; Swarbrick ET; Grace RH; Gent AE; Hellier MD
    Aliment Pharmacol Ther; 1996 Apr; 10(2):157-63. PubMed ID: 8730244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
    Nakshabendi IM; Duncan A; Russell RI
    Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulmonary infiltration and eosinophilia associated with sulfasalazine therapy for ulcerative colitis: a case report and review of literature.
    Yamakado S; Yoshida Y; Yamada T; Kishida T; Kobayashi M; Nomura T
    Intern Med; 1992 Jan; 31(1):108-13. PubMed ID: 1348965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sulfasalazine enema in acute left-sided ulcerative colitis (author's transl)].
    Frimberger E; Frühmorgen P; Kühner W; Ottenjann R
    MMW Munch Med Wochenschr; 1980 Sep; 122(36):1233-5. PubMed ID: 6108506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desensitization for sulfasalazine-induced skin rash in a patient with ulcerative colitis.
    Akahoshi K; Chijiiwa Y; Kabemura T; Okabe H; Akamine Y; Nawata H
    J Gastroenterol; 1994 Dec; 29(6):772-5. PubMed ID: 7874275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
    Rachmilewitz D
    BMJ; 1989 Jan; 298(6666):82-6. PubMed ID: 2563951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
    Tolia V
    Am J Gastroenterol; 1992 Aug; 87(8):1029-32. PubMed ID: 1353658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy of coated, oral 5-aminosalicylic acid (Claversal) and sulphasalazine for maintaining remission of ulcerative colitis. International Study Group.
    Rutgeerts P
    Aliment Pharmacol Ther; 1989 Apr; 3(2):183-91. PubMed ID: 2577483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulphasalazine in ulcerative colitis.
    Drug Ther Bull; 1967 Nov; 5(24):93-4. PubMed ID: 4384228
    [No Abstract]   [Full Text] [Related]  

  • 39. Sulphasalazine hepatotoxicity after 15 years' successful treatment for ulcerative colitis.
    Lennard TW; Farndon JR
    Br Med J (Clin Res Ed); 1983 Jul; 287(6385):96. PubMed ID: 6134567
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis.
    Riley SA; Mani V; Goodman MJ; Herd ME; Dutt S; Turnberg LA
    Gastroenterology; 1988 Jun; 94(6):1383-9. PubMed ID: 2896139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.